Skip to main content
RAPS Convergence 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Requires Pre-Registration or Sign-up
Requires Pre-Registration or Sign-up
Additional Registration Fee
Additional Registration Fee
Invitation Only
Invitation Only
Student Program
Student Program
Networking Opportunity
Networking Opportunity
RAPS Focus Area
RAPS Focus Area
Back

Junyang Wang

US Director, Global Regulatory and Scientific Policy
EMD Serono

Junyang Wang, MSc, is a public health and policy professional with a combined 15 years of regulatory policy and stakeholder engagement experience across the US Food and Drug Administration (FDA), Edelman, and now EMD Serono. As the US Director for Global Regulatory and Scientific Policy (GRASP), he leads company-wide regulatory policy efforts within clinical trial diversity and digital health. Prior to joining EMD Serono, he worked at the U.S. Food and Drug Administration (FDA) for over seven years leading digital health innovation, policy and guidance writing within the Digital Health Center of Excellence in the Center for Devices and Radiological Health (CDRH) as well as clinical trial policy and stakeholder engagement in the Center for Drug Evaluation and Research (CDER). His breadth of work has spanned innovating new regulatory paradigms for digital health, understanding biologic variability to drug response, and fostering transparency and meaningful engagement at FDA. He completed his Masters of Science in Global Health as well as a Bachelors of Science in Psychology from Duke University.

Disclosure information not submitted.

Presentation(s):